Gastrointestinal involvement in systemic sclerosis. An underestimated complication;Gastrointestinale beteiligung bei systemischer sklerose. Eine häufig verharmloste komplikation

Hautarzt

Volumn 58, Issue 10, 2007, Pages 844-850

  Saar, P ^a   Schmeiser, T ^a   Tarner, I H ^a   Muller Ladner U ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Connective tissue disease; Esophageal involvement; Gastrointestinal involvement; Organ involvement; Systemic sclerosis

Indexed keywords

AUTOIMMUNE DISEASE; CONNECTIVE TISSUE DISEASE; COOPERATION; DERMATOLOGY; DISEASE COURSE; GASTROINTESTINAL TRACT; HUMAN; IMMUNE SYSTEM; LIFE; MICROCIRCULATION; MONITORING; MORBIDITY; MORTALITY; ORGAN; PATIENT CARE; PHYSICIAN; PREVALENCE; REVIEW; SKIN FIBROSIS; SKINFOLD; SYSTEMIC SCLEROSIS; THERAPY DELAY; THREAT;

BLIND LOOP SYNDROME; CELL MEMBRANE PERMEABILITY; COOPERATIVE BEHAVIOR; DEGLUTITION DISORDERS; DIAGNOSIS, DIFFERENTIAL; DIARRHEA; ENDOSCOPY, GASTROINTESTINAL; ESOPHAGEAL DISEASES; FECAL INCONTINENCE; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL DISEASES; GASTROINTESTINAL MOTILITY; GASTROINTESTINAL TRANSIT; HUMANS; MUSCLE, SMOOTH; PATIENT CARE TEAM; SCLERODERMA, SYSTEMIC; SKIN; ULTRASONOGRAPHY;

EID: 35848955226     PISSN: 00178470     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00105-007-1380-3     Document Type: Review

References (20)

1. Saar P, Müller A, Noethe M et al. (2006) Evaluation des Pilotfragebogens zu Art und Ausmaß der gastrointestinalen Beteiligung bei Patienten mit systemischer Sklerose (limitiert/diffus) im Rahmen des Deutschen Netzwerks für systemische Sklerodermie. Z Rheumatol [Suppl 1]: 61
2. Walker UA, Tyndall A, Czirják L et al. (2007) Clinical risk assessment of organ manifestations in systemic sclerosis - a report from the EULAR Scleroderma Trials and Research (EUSTAR) group data base. Ann Rheum Dis 66: 754-763
3. Sjøgren J (1994) Gastrointestinal motility disorders in scleroderma. Arthritis Rheum 37: 1265-1282
4. Jaovisidha K, Csuka ME, Almagro UA, Soergel KH (2005) Severe gastrointestinal involvement in systemic sclerosis: a report of five cases and review of the literature. Semin Arthritis Rheum 34: 689-702
5. Manetti M, Neumann E, Milia AF et al. (2007) Severe fibrosis and increased expression of fibrogenic cytokines in the gastric wall of systemic sclerosis patients. Arthritis Rheum (in press)
6. Zuber JP, Spertini F (2006) Immunological basis of systemic sclerosis. Rheumatology 45: iii23-iii25
7. Stoumazios SK, Voulgari PV, Potsis K et al. (2006) Esophageal involvement in scleroderma: Gastroesophageal reflux, the common problem. Semin Arthritis Rheum 36: 173-181
8. Weber P, Ganser G, Frosch M et al. (2000) Twenty-four hour intraesophageal pH monitoring in children and adolescents with scleroderma and mixed connective tissue disease. J Rheumatol 27: 2692-2695
9. Wipff J, Allanore Y, Soussi F et al. (2005) Prevalence of Barrett's esophagus in systemic sclerosis. Arthritis Rheum 52: 2882-2888
10. Bortolotti M, Turba E, Tosti A et al. (1991) Gastric emptying and interdigestive antroduodenal motility in patients with esophageal scleroderma. Am J Gastroenterol 86: 743-747
11. Franck-Larsson K, Hedenstrom H, Dahl R, Ronnblom A (2003) Delayed gastric emptying in patients with diffuse versus limited systemic sclerosis, unrelated to gastrointestinal symptoms and myoelectric gastric activity. Scand J Rheumatol 32: 348-355
12. Sjölund K, Bartosik I, Lindberg G et al. (2005) Small intestinal manometry in patients with systemic sclerosis. Eur J Gastroenterol Hepatol 17: 1205-1212
13. Caserta L, Magistris L de, Secondulfo M et al. (2003) Assessment of intestinal permeability and orocecal transit time in patients with systemic sclerosis: Analysis of relationships with epidemiologic and clinical parameters. Rheumatol Int 23: 226-230
14. Marie I (2006) Gastrointestinal involvement in systemic sclerosis. Presse Med 35: 1952-1965
15. Massone C, Milone L, Parodi A et al. (2002) Anorectal involvement is frequent in limited systemic sclerosis. Acta Derm Venereol 82: 446-448
16. Linke R, Meier M, Muenzing W et al. (2005) Prokinetic therapy: What can be measured by gastric scintigraphy? Nucl Med Commun 26: 527-533
17. Wang SJ, Lan JL, Lan JL et al. (2002) Effects of cisapride on colonic transit in patients with progressive systemic sclerosis. Clin Rheumatol 21: 43-45
18. Wang SJ, Lan JL, Chen DY et al. (2001) Colonic transit disorders in systemic sclerosis. Clin Rheumatol 20: 251-254
19. Wollaston DE, Xu X, Tokumaru O et al. (2005) Patients with systemic sclerosis have unique and persistent alterations in gastric myoelectrical activity with acupressure to Neiguan point PC6. J Rheumatol 32: 494-501
20. Sallam H, McNearney TA, Chen JD (2006) Systematic review: Pathophysiology and management of gastrointestinal dysmotility in systemic sclerosis (scleroderma). Aliment Pharmacol Ther 23: 691-712